Among the companies with shares expected to actively trade in
Monday's session are Biofuel Energy Corp. (BIOF), General Motors
Co. (GM) and Prana Biotechnology Ltd. (PRAN).
David Einhorn's Greenlight Capital increased its stake in
ethanol producer Biofuel Energy and proposed that the company
acquire a real-estate developer for $275 million. Shares surged 35%
to $4.25 premarket.
The U.S. Food and Drug Administration has approved Biogen Idec
Inc.'s (BIIB) treatment for hemophilia B, a largely inherited
disorder that is the second-most common type of hemophilia. Shares
edged up 1.9% to $299.56 premarket.
General Motors said it is recalling 824,000 more vehicles in the
U.S., the latest in a string of recalls for the auto maker in
recent days. Shares slid 0.8% to $34.45 premarket.
Prana Biotechnology said its PBT2 treatment didn't meet its
primary goals as a treatment for Alzheimer's disease patients in a
Phase 2 study. Shares slumped 66% to $3.35 in recent premarket
trading.
Watch List:
Home-health provider Amedisys Inc. (AMED) disclosed a plan to
close about 29 care centers and consolidate an additional 25,
actions that are expected to result in non-recurring charges of
between $7 million to $9 million.
B/E Aerospace Inc. (BEAV) on Monday raised its yearly earnings
guidance as it is on pace to post record quarterly bookings and
said it had reached a $145 million deal to buy an oilfield services
company.
Cal-Maine Foods Inc. (CALM) said its fiscal third-quarter sales
and profit grew in large part because of higher prices and
continued growth in its specialty-egg business.
Forest Laboratories Inc. (FRX) and Hungary's Richter Gedeon PLC
reported positive top-line results from a Phase IIb study of an
experimental antipsychotic drug for the treatment of bipolar
depression. The results from the study come after the companies
completed Phase III studies for cariprazine for the treatment of
bipolar mania and schizophrenia.
Helen of Troy Ltd.'s (HELE) new chief executive, Julien R.
Mininberg, will join the board and is expected to be nominated to
be elected to the panel at the company's next annual shareholder
meeting. Mr. Mininberg took over as CEO at the beginning of March.
He was appointed in January to succeed Gerald J. Rubin, who left to
become the chief of a real-estate firm in El Paso, Texas.
Johnson & Johnson (JNJ) said it has accepted Carlyle Group
LP's (CG) offer to acquire its ortho-clinical diagnostics business
for about $4 billion. New Brunswick, N.J.-based J&J, which
makes everything from prescription drugs and medical devices to
Band Aids and Listerine mouth wash, has been shedding slow-growing
products and businesses.
MagnaChip Semiconductor Corp. (MX) said Chief Financial Officer
Margaret Sakai has resigned, just over two weeks after being
removed as the company's chief accounting officer, as the South
Korean chip maker continues its review of accounting practices and
procedures.
Sally Beauty Holdings Inc. (SBH) said a continuing data breach
investigation showed more credit-card records may have been stolen
than the beauty-supplies company previously estimated.
Standard & Poor's Ratings Services lowered its rating on
Target Corp. (TGT), citing a weaker-than-expected fourth quarter
due to the retailer's massive data breach and mounting losses from
its push into Canada.
UTi Worldwide Inc. (UTIW) said its loss narrowed in the fiscal
fourth-quarter, but the logistics and supply-chain management
company reported a decline in revenue in its freight-forwarding
segments. UTi has taken steps to reduce costs and has been
deploying a new freight-forwarding operating systems.
Write to John Kell at john.kell@wsj.com and Lauren Pollock at
lauren.pollock@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires